16:30 EST Ginkgo Bioworks (DNA) still sees FY25 revenue $167M-$187M, consensus $177.07M
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNA:
- Ginkgo Bioworks reports Q3 EPS ($1.45), consensus ($1.24)
- Ginkgo Bioworks awarded $22.2M contract through BARDA BioMaP-Consortium
- Private Markets: Polymarket planning U.S. return with sports focus
- Ginkgo Bioworks extends partnership with Bayer
- Ginkgo Bioworks announces collaboration with STRM.BIO, UBC